Literature DB >> 6246965

Adenosine diphosphate ribosylation of histone H1 by purified calf thymus polyadenosine diphosphate ribose polymerase.

H Okazaki, C Niedergang, P Mandel.   

Abstract

The mechanism of poly ADPR synthesis and the transfer of poly ADPR to histone H1 molecule by electrophoretically homogenous calf thymus poly ADPR polymerase containing DNA was examined. 1) An acid insoluble radioactive complex (I) was obtained after incubation of purified enzyme with [3H] NAD. The stability of (I) was examined by SDS-polyacrylamide gel electrophoresis. The complex (I) was stable against acid, SDS, urea, DNase and RNase, but labile against pronase, trypsin, alkali and snake venom phosphodiesterase treatment. The molecular weight of (I) was about 130 000 daltons estimated by SDS-gel electrophoresis. The radioactive products of successive alkali, venom phosphodiesterase and Pronase hydrolysis of (I) were PR-AMP and AMP. The mean chain length of poly ADPR of (I) was 20--30. These results suggest that the complex (I) is poly ADP-ribosylated poly ADPR polymerase. 2) Besides (I), a second radioactive peak (II) was observed when acid insoluble products obtained from an incubation mixture containing purified poly ADPR polymerase, [3H] NAD and purified histone H1 were analyzed on SDS-polyacrylamide gel electrophoresis. The molecular weight of (II) was estimated to be about 23 000 daltons. The complex (II) is eluted like histone H1 on CM-cellulose columns and hydrolyzed by alkali, trypsin and snake venom phosphodiesterase but not by DNase, or RNase. The comples (II) was extracted selectively by 5 per cent perchloric acid or 5 per cent trichloroacetic acid from mixture of (I) and (II). The mean chain length of poly ADPR of complex (II) and 5--20; these results suggest that the complex (II) is poly ADP-ribosylated histone H1. 3) Results 1) and 2) indicate that purified DNA containing, thus DNA independent, poly ADPR polymerase catalyzes two different reactions, the ADPR transfer onto the enzyme itself and onto histone H1 and the elongation of ADPR chains. Dimeric forms of ADP-ribosylated histone H1 was not observed. Free poly ADPR was observed only when very small quantities of enzyme were used for incubation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246965     DOI: 10.1016/s0300-9084(80)80190-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Histone-dependent and histone-independent forms of an ADP-ribosyltransferase from human and turkey erythrocytes.

Authors:  J Moss; S J Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Mono- and poly-ADP-ribosylation of proteins in mouse kidney after castration and testosterone treatment.

Authors:  A Gartemann; R Bredehorst; K Wielckens; W H Strätling; H Hilz
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

4.  Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme.

Authors:  J Moss; M K Jacobson; S J Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure.

Authors:  G G Poirier; G de Murcia; J Jongstra-Bilen; C Niedergang; P Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Poly(ADP-ribose) polymerase auto-modification and interaction with DNA: electron microscopic visualization.

Authors:  G de Murcia; J Jongstra-Bilen; M E Ittel; P Mandel; E Delain
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

Review 7.  Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance.

Authors:  Dae-Seok Kim; Cristel V Camacho; W Lee Kraus
Journal:  Exp Mol Med       Date:  2021-01-25       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.